Clinical trials for Post-transplant lymphoproliferative disease
12 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGPhase 2NCT06723457Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell LymphomaNorthwestern University · PI: Reem Karmali, MD
- RECRUITINGPHASE1, PHASE2NCT07368634Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell TransplantationDaihong Liu
- RECRUITINGPhase 2NCT06954805Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)Jennifer Amengual · PI: Jennifer Amengual, MD
- RECRUITINGPHASE1, PHASE2NCT07438067EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell TransplantationDaihong Liu
- ACTIVE NOT RECRUITINGNCT06422715PTLD: Multicentric Retrospective StudyFondazione Italiana Linfomi - ETS · PI: Federica Cavallo, MD
- RECRUITINGPHASE1, PHASE2NCT06040320Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)Washington University School of Medicine · PI: Neha Mehta-Shah, M.D.
- RECRUITINGPhase 2NCT05453396Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell MalignanciesUniversity of Washington · PI: Stephen D. Smith
- RECRUITINGPhase 2NCT05786040Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative DisorderTimothy Voorhees · PI: Timothy J Voorhees, MD, MSCR
- RECRUITINGPhase 4NCT04989491Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney AllograftUniversity Hospital, Strasbourg, France
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03131934Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ TransplantUniversity College, London · PI: Prof. Persis Amrolia
- ACTIVE NOT RECRUITINGPhase 1NCT02663297Administration of T Lymphocytes for Prevention of Relapse of LymphomasUNC Lineberger Comprehensive Cancer Center · PI: Natalie Grover, MD
- ACTIVE NOT RECRUITINGN/ANCT01231269Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of LymphomaUniversitaire Ziekenhuizen KU Leuven · PI: vincent vandecaveye, MD PhD